Article
Unoprostone increases outflow facility to reduce IOP
Author(s):
Fort Lauderdale, FL-An increase in outflow facility appears to be the mechanism by which unoprostone isopropyl ophthalmic solution (Rescula 0.15%, Novartis) reduces IOP, said Carol B. Toris, PhD.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
